BDBM457084 (2S,3R)-2,3-dihydroxy-3-(6-(5- (4-(trifluoromethyl)phenyl)- 3,4-dihydroisoquinolin-2(1H)- yl)pyridin-2-yl)propanamide::US10738026, Compound 26
SMILES: NC(=O)[C@@H](O)[C@H](O)c1cccc(n1)N1CCc2c(C1)cccc2-c1ccc(cc1)C(F)(F)F
InChI Key: InChIKey=FFFYSIINVOIAJZ-YADHBBJMSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sodium channel protein type 9 subunit alpha (Homo sapiens (Human)) | BDBM457084 ((2S,3R)-2,3-dihydroxy-3-(6-(5- (4-(trifluoromethyl...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 51 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purdue Pharma L.P. US Patent | Assay Description On the day of experimentation, cells are prepared by removing media and digesting with appropriate enzymes to suspend cells in external solution.Whol... | US Patent US10738026 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium channel protein type 9 subunit alpha (Homo sapiens (Human)) | BDBM457084 ((2S,3R)-2,3-dihydroxy-3-(6-(5- (4-(trifluoromethyl...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 251 | n/a | n/a | n/a | n/a | n/a | n/a |
Purdue Pharma L.P. US Patent | Assay Description The assay buffer was formulated by removing 120 mL from a 1 L bottle of fresh, sterile dH2O (Mediatech, Herndon, Va.) and adding 100 mL of 10×HBSS th... | US Patent US10738026 (2020) | |||||||||||
More data for this Ligand-Target Pair |